Reprise Biomedical, Inc.
Last verified 2026-06-14. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.4Mattributed |
|---|---|
| Latest round | Funding round, $1.4M, 2026-05-14attributed |
| Founded | unknown |
| Headquarters | Plymouth, MN |
| Industry | bio |
| Stage | unknown |
| Website | reprisebio.com |
Early commercial-stage biologics wound-care company with the Miro3D perfusion-decellularized wound matrix.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-05-14 | Funding round | $1.4M | undisclosed |
Detected tech stack
doubleclick floodlight, font awesome, google analytics, google tag manager, http/3, hubspot, jquery migrate 3.4.1, jquery mobile, monsterinsights 10.2.2, mysql, php, site kit 1.180.0
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $1.4M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $1.4M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | reprisebio.com, read 2026-06-14 |
| Description | self-reported | reprisebio.com, read 2026-06-14 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $1.4M, 2026-05-14 → Funding round, $1.4M, 2026-05-14, sec-edgar, No document URL on file | Latest round | seed, $1.4M, 2026-05-14 → Funding round, $1.4M, 2026-05-14 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes